Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Collino, Massimo, Rogazzo, Mara, Pini, Alessandro, Benetti, Elisa, Rosa, Arianna Carolina, Chiazza, Fausto, Fantozzi, Roberto, Bani, Daniele, Masini, Emanuela
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons 2013
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://ncbi.nlm.nih.gov/pubmed/24079335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.12120
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы